Safety and feasibility of esophagectomy following neoadjuvant immunotherapy combined with chemotherapy for esophageal squamous cell carcinoma

HIGHLIGHTS

  • who: Yi-Min Gu et al. from the University of Port Harcourt Teaching Hospital, Nigeria have published the Article: Safety and Feasibility of Esophagectomy Following Neoadjuvant Immunotherapy Combined with Chemotherapy for Esophageal Squamous Cell Carcinoma, in the Journal: (JOURNAL) of 15/06/2021
  • what: The aim of this study was to analyze the clinical data, perioperative outcomes, and oncologic outcome data of ICIs plus chemotherapy as a neoadjuvant therapy regimen for the treatment of patients with locally advanced ESCC in the institution .
  • future: These shortterm outcomes may be helpful for future trials and . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?